TipRanks
Go Ultimate55% OFF

AN2 Therapeutics, Inc. (ANTX) Cash flow

AN2 Therapeutics, Inc. Cash Flow

ANTX's free cash flow for Q2 2026 was $-7.00M. For the 2026 fiscal year, ANTX's free cash flow was increased by $0.00 and operating cash flow was $-7.00M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -29.83M$ -49.26M$ -53.29M$ -33.46M$ -20.48M
$ 28.31M$ 54.59M$ -43.28M$ -21.77M$ -50.02M
$ 113.00K$ 372.00K$ 84.99M$ 70.36M$ 78.53M
$ 19.94M$ 21.35M$ 15.65M$ 27.22M$ 12.10M
$ -29.83M$ -49.26M$ -53.29M$ -33.46M$ -20.48M

Currency in USD

AN2 Therapeutics, Inc. Cash Flow

-75M-50M-25M025M50M75M100M2019202020212022202320242025OperatingInvestingFinancing